...
首页> 外文期刊>International Journal of Pharmaceutics >Patterning poly(maleic anhydride-co-3,9-divinyl-2,4,8,10-tetraoxaspiro (5.5) undecane) copolymer bioconjugates for controlled release of drugs
【24h】

Patterning poly(maleic anhydride-co-3,9-divinyl-2,4,8,10-tetraoxaspiro (5.5) undecane) copolymer bioconjugates for controlled release of drugs

机译:图案化聚(马来酸酐-co-3,9-二乙烯基-2,4,8,10-四氧六环(5.5)十一烷)共聚物生物共轭物以控制药物释放

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Owing to the special characteristics and abilities polymeric networks have received special interest for a range of biomedical applications especially for drug delivery systems. This study was devoted to preparation of new polymeric compounds based on maleic anhydride and 3,9-divinyl-2,4,8,10-tetraoxaspiro (5.5) undecane copolymer (poly maleic anhydride-co-3,9-divinyl-2,4,8,10-tetraoxaspiro (5.5) undecane) (PMAU) patterned as a network for bioconjugation and tested as drug carrier systems. The PMAU copolymer was improved in its functionality by opening the maleic anhydride ring with different amounts of erythritol, which is free of side effects in regular use and a multifunctional compound, and also confers antioxidant character for the new compounds. The new polymeric matrices were loaded with acetaminophen, codeine and their fixed dose combinations. The investigation demonstrated the capability of the new structures to be used as polymer networks for linking bioactive compounds and to perform controlled delivery. The physico-chemical investigations Fourier transform infrared spectroscopy (FTIR) spectra, contact angle, zeta potential (ZP - z, PMAU and its derivatives samples loaded with medicines present decreased values of zeta potential attesting the bioconjugate formation and as well their stability), and hydrodynamic radius, near infrared chemical imaging evaluation (new specific bands being registered for bio-conjugate with acetaminophen around of 1150-1200 nm and 1700 nm, and also between 1150 and 1200 nm in case of the codeine bio-conjugate), scanning electron microscopy (SEM) studies, X-ray diffraction analysis evidenced the formation of the bioconjugates in relation to the chemical composition of the polymer matrices, while in vitro release study and in vivo tests confirm the capacity for drug delivery of the prepared bioactive systems. (C) 2015 Elsevier B.V. All rights reserved.
机译:由于其特殊的特性和能力,聚合物网络已在一系列生物医学应用中引起了特别的兴趣,特别是对于药物输送系统。这项研究致力于制备基于马来酸酐和3,9-二乙烯基-2,4,8,10-四氧六环(5.5)十一烷共聚物的新聚合物(聚马来酸酐-co-3,9-二乙烯基-2, 4,8,10-四氧杂螺环(5.5)十一烷)(PMAU)图案化为可用于生物偶联的网络,并已作为药物载体系统进行了测试。通过用不同量的赤藓糖醇打开马来酸酐环,可以改善PMAU共聚物的功能,在常规使用和多官能化合物中没有副作用,并且还赋予新化合物抗氧化性。新的聚合物基质中装有对乙酰氨基酚,可待因及其固定剂量组合。研究表明,这种新结构可用作连接生物活性化合物并控制传递的聚合物网络的能力。物理化学研究傅立叶变换红外光谱(FTIR)光谱,接触角,ζ电位(装有药物的ZP-z,PMAU及其衍生物样品的zeta电位值降低,证明了生物缀合物的形成及其稳定性),以及流体力学半径,近红外化学成像评估(对于可对乙酰氨基酚的生物共轭物,新的特定谱带已登记在1150-1200 nm和1700 nm附近,如果是可待因生物共轭物,则在1150和1200 nm之间),扫描电子显微镜(SEM)研究,X射线衍射分析证明了与聚合物基质化学组成相关的生物共轭物的形成,而体外释放研究和体内试验证实了所制备生物活性系统的药物递送能力。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号